US Patent Litigations are now available. Check here

Explore patent oppositions filed by Avencell Europe against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2651442Universal Anti-Tag Chimeric Antigen Receptor-Expressing T Cells And Methods Of Treating CancerUNIVERSITY OF MARYLANDJan 20, 2021